Synthesis of the Anti-tumor Marcrolide Amphidinolide C
Synthesis of the Anti-tumor Marcrolide Amphidinolide C
批准号:
6782520
负责人:
JOHN B SHOTWELL
金额:
$2.5万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-15 至 2005-04-14
中文摘要
描述(由申请人提供):该提案详细介绍了针对两萜内酯c的全合成的研究。两萜内酯是一组结构多样的30多种大环内酯,具有有效和选择性的抗肿瘤特性。在这一类中,无与伦比的结构异质性表明,在治疗癌症方面,有许多机制上独特的进展,或者是一种未识别的细胞内效应,在配体结合方面表现出巨大的混杂性。两萜内酯的作用机制尚未得到研究,主要是由于缺乏可用的天然产物、类似物和生化试剂(例如,基于两萜内酯的亲和探针和/或色谱柱等)。本文提出了一种串联不对称Heck/烯醇醚氧化策略,用于制备手性烯丙基1,2-抗二醇,并描述了其在制备两萜内酯c的高氧合C3-C9区的应用。该路线高度收敛,将扩大对映选择性和双非对映选择性[3+2]环化策略的范围,用于高效构建四氢呋喃。这将是首次完全合成两萜内酯C。
英文摘要
DESCRIPTION (provided by applicant): This proposal details studies directed toward the total synthesis of amphidinolide C. The amphidinolides, a structurally diverse group of over 30 macrolides, exhibit potent and selective anti-tumor profiles. The unparalleled structural heterogeneity in this class is indicative either of a host of mechanistically unique inroads to the treatment of cancers or a single unidentified intracellular effector which exhibits tremendous promiscuity in ligand binding. The mechanisms of action of the amphidinolides have gone unstudied, primarily due to a lack of available natural products, analogs, and biochemical reagents (e.g., amphidinolide-based affinity probes and/or columns, etc.). The proposed synthesis involves the development of a tandem asymmetric Heck/enol-ether oxidation strategy for the preparation of chiral allylic 1,2-anti diols and describes its application toward the preparation of the highly oxygenated C3-C9 region of amphidinolide C. The route is highly convergent, will expand the scope of enantioselective and doubly-diastereoselective [3+2] annulation strategies for the efficient construction of tetrahydrofurans, and will represent the first total synthesis of amphidinolide C.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synthesis of the Anti-tumor Marcrolide Amphidinolide C
-
批准号:6692257
-
项目类别:
-
资助金额:$3.97万
-
财政年份:2003
-
负责人:JOHN B SHOTWELL
-
依托单位:
海外基金